Fredrik Herslow
Chairman of the Board
Born 1961. Board Member since 2025.
Has held several senior executive positions across various industries and companies. Served, among other roles, as CFO for KABI and CFO for KABI Biopharma—companies that later merged with Pharmacia and are now part of Pfizer; CFO for SAAB Automobile; CEO of Nova Medical Calab, a company that acquired and operated clinical laboratories and later became the foundation of Unilab; CEO of Wilh. Sonesson when the company was reintroduced on the Stockholm Stock Exchange in 1999; CEO of Hamlet Pharma at its listing on Spotlight Stock Market in 2015; and CEO of SelectImmune Pharma when the company was listed on the same marketplace in 2019.
Holdings: 1,273,493 shares, privately and through companies.
Additional ongoing assignments:
Great Deals in Sweden AB | Chairman of the Board
Herslow & Partners AB | Board Member and CEO
Herslow & Partners Corp. Fin. AB | Board Member
Gallebjer AB | Board Member
ArcticIron AB | Board Member
Completed assignments (past five years):
- Biomedica Norden AB | Chairman of the Board
- SelectImmune Pharma AB | External CEO
Current and historical ownership (past five years, ?10%):
- Gallebjer AB | 100% | Ongoing
- Herslow & Partners AB | 100% | Ongoing
- Herslow & Partners Corp. Fin. AB | 100% | Ongoing
- ArcticIron AB | 100% | Ongoing
- Great Deals in Sweden AB*) | 50% | Ongoing
- Biomedica Norden AB | 40% | Ended
*) Via capital insurance
Stefan Sallerfors
Board MEMBER
Born 1957. Board Member since 2025.
Holds a medical degree from Lund University (1981), licensed physician since 1983, and specialist in Medical Radiology since 1987. Has extensive experience in both healthcare management and business leadership across the Life Science and healthcare sectors.
Founder and CEO of MEDVICE design AB since 1987, working as a management and organizational consultant with assignments focusing on business development for the welfare industry — including the development of products and services that support medical and technological progress, as well as demographic changes. Provides analytical and advisory services for listed companies in Life Science, including IPO evaluations and information assessments.
Previous assignments include Group IT Director for HMA Invest and CEO of subsidiaries Alfa Kommun och Landsting AB and Safe Care Svenska AB (2019–2020), Transformation Partner in Perioperative Medicine and Intensive Care at Karolinska University Hospital (2015–2017), Deputy CEO at Solving Efeso Nordic (2011–2012), and Research Director at Länsförsäkringar AB (2006–2009), where he established the “Research & Future” division integrating research initiatives into the bank and insurance business.
He has also held several senior management roles in healthcare, including CEO of Helsingborg Hospital AB (2000–2003), Head of Radiology at Helsingborg and Ängelholm Hospitals (1991–1999), and Managing Director of GE Medical Systems Sweden (1995–1996).
Holdings: 3,243,140 shares privately and through MEDVICE Design AB.
Additional ongoing assignments:
- MEDVICE Design AB | Chairman and CEO
- Trigonum AB | Chairman
- Alfa eCare International AB | Board Member
Previous appointments (past five years):
- HMA Invest AB | Group IT Director
- Alfa Kommun och Landsting AB | CEO
- Safe Care Svenska AB | CEO
Current and historical holdings (past five years, ?10%):
- MEDVICE Design AB | 100% | Ongoing
- Trigonum AB | 100% | Ongoing
Ulf Jensen
Board MEMBER
Born: 1963. Board Member since 2024.
Ulf Jensen is one of the founders of ORTELIUS AB and has extensive experience in building and leading a consulting business. Accustomed to working closely with clients and their management, on issues surrounding Digital Transformation and what is required to succeed.
Holdings: 12,474,012 shares after the Transaction through Providence Holding AB.
Additional ongoing assignments:
• Chairman of the Board of Sapera AB.
• Board member of Providence Holding AB. Ortelius AB, Ortelius Thinktank AB, inorigo AB and ORTELIUS S2C AB.
• CEO of Inorigo AB and Ortelius AB.
Senior Management
Anders Berglund
CEO
Born: 1975. CEO since: 2025
Anders Berglund brings over two decades of international leadership experience from organizations such as Google, Schibsted and Skilling Group, where he served as CEO and later Executive Chairman. His background spans strategic advisory roles, board leadership and senior executive management across multiple sectors including technology, finance and defense.
His appointment is described as signaling a strategic shift for ORTELIUS towards a more growth-oriented development phase, with an increased focus on digital development and business expansion.
Holdings: Anders Berglund holds no shares.
Herman Weberg
CFO
Born: 1976. CFO since: 2025
Herman Weberg has served as Senior Advisor to ORTELIUS over the past six months and now takes on the role of Chief Financial Officer. Herman Weberg brings experience from the financial services and audit industry, having worked for more than a decade as an Authorized Public Accountant at EY, followed by several senior financial leadership positions. Most recently, he served as Interim Group CFO at Insuro Technologies. Herman Weberg holds a Master’s Degree in Business Administration from Lund University.
Additional ongoing assignments:
• Chairman and shareholder in HK Art & Consulting AB and Flexcompetence AB.
Holdings: Herman Weberg holds no shares.